Sana Biotechnology Statistics
Total Valuation
SANA has a market cap or net worth of $451.11 million. The enterprise value is $445.42 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANA has 225.56 million shares outstanding. The number of shares has increased by 17.36% in one year.
| Current Share Class | 225.56M |
| Shares Outstanding | 225.56M |
| Shares Change (YoY) | +17.36% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 8.85% |
| Owned by Institutions (%) | 58.56% |
| Float | 134.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.16 |
| P/TBV Ratio | 48.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.47.
| Current Ratio | 3.40 |
| Quick Ratio | 3.16 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.44% and return on invested capital (ROIC) is -34.03%.
| Return on Equity (ROE) | -71.44% |
| Return on Assets (ROA) | -23.84% |
| Return on Invested Capital (ROIC) | -34.03% |
| Return on Capital Employed (ROCE) | -52.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.08M |
| Employee Count | 194 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.54% in the last 52 weeks. The beta is 1.75, so SANA's price volatility has been higher than the market average.
| Beta (5Y) | 1.75 |
| 52-Week Price Change | -73.54% |
| 50-Day Moving Average | 1.98 |
| 200-Day Moving Average | 3.23 |
| Relative Strength Index (RSI) | 57.17 |
| Average Volume (20 Days) | 2,538,075 |
Short Selling Information
The latest short interest is 40.07 million, so 17.77% of the outstanding shares have been sold short.
| Short Interest | 40.07M |
| Short Previous Month | 40.61M |
| Short % of Shares Out | 17.77% |
| Short % of Float | 29.74% |
| Short Ratio (days to cover) | 8.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -214.90M |
| Pretax Income | -244.90M |
| Net Income | -208.67M |
| EBITDA | -199.49M |
| EBIT | -214.90M |
| Earnings Per Share (EPS) | -$0.88 |
Full Income StatementBalance Sheet
The company has $104.70 million in cash and $99.01 million in debt, giving a net cash position of $5.69 million or $0.03 per share.
| Cash & Cash Equivalents | 104.70M |
| Total Debt | 99.01M |
| Net Cash | 5.69M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 209.08M |
| Book Value Per Share | 0.93 |
| Working Capital | 79.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$206.18 million and capital expenditures -$17.72 million, giving a free cash flow of -$223.90 million.
| Operating Cash Flow | -206.18M |
| Capital Expenditures | -17.72M |
| Free Cash Flow | -223.90M |
| FCF Per Share | -$0.99 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |